RA Capital Buys $43.1M of PepGen Stock at the $5.00 Offering Price
PEPG has more than doubled off its 52-week low of $1.31.
Summary
RA Capital, a PepGen director and 10% owner, bought 8,625,000 shares at $5.00 for $43.1M — about a third of the company's $125M offering — lifting its combined holdings to 27,179,273 shares.
Key Events · Ownership and Investor Activity · PEPG
-
RA Capital Takes $43.1M of Offering
RA Capital Healthcare Fund bought 8,625,000 shares at $5.00 on 2026-11-13 for $43,125,000 — 8,625,000 x $5.00 = $43,125,000.
-
Roughly a Third of the Deal
The purchase covers 8,625,000 of the 25 million shares in PepGen's $125M offering priced 2026-11-12, leaving less new stock in other hands.
-
Holdings Rise to 27.2M Shares
Post-transaction holdings total 27,179,273 shares across the Fund, Nexus Fund II and a separately managed account.
-
Entry Above Current Quote
The $5.00 purchase price is above today's $3.89 stock price, so the new position is already below cost.
Analysis · PEPG · Life Sciences
RA Capital, a director and 10% owner, put $43.1M of its own money into PepGen's just-priced $125M offering, taking 8,625,000 of the 25 million shares at $5.00 each. That is roughly a third of the entire deal absorbed by one related party, which removes a large chunk of the new-share overhang and shows the fund backing the company right after the positive FREEDOM2-DM1 data. The purchase price is above today's $3.89 quote, so the position is already underwater on paper — the conviction is in the size, not the entry point. Post-transaction, RA Capital entities hold 27,179,273 shares.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PEPG was trading at $3.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $268.7M. The 52-week trading range was $1.31 to $7.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.